Ocular Therapeutix, Inc.
OCUL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,150 | $1,602 | $1,242 | $1,435 |
| - Cash | $345 | $391 | $350 | $392 |
| + Debt | $77 | $77 | $76 | $76 |
| Enterprise Value | $1,882 | $1,287 | $968 | $1,119 |
| Revenue | $15 | $13 | $11 | $17 |
| % Growth | 8.1% | 25.8% | -37.4% | – |
| Gross Profit | $13 | $12 | $9 | $16 |
| % Margin | 87.8% | 85.6% | 88.2% | 92.8% |
| EBITDA | -$65 | -$64 | -$60 | -$44 |
| % Margin | -449.3% | -473.8% | -561.7% | -259.5% |
| Net Income | -$69 | -$68 | -$64 | -$48 |
| % Margin | -477.3% | -503.9% | -598.7% | -283.3% |
| EPS Diluted | -0.38 | -0.39 | -0.38 | -0.29 |
| % Growth | 2.6% | -2.6% | -31% | – |
| Operating Cash Flow | -$51 | -$55 | -$45 | -$39 |
| Capital Expenditures | -$6 | -$1 | -$2 | -$0 |
| Free Cash Flow | -$57 | -$56 | -$47 | -$40 |